HDAC9 and central nervous system cancer: Other trials are evaluating HDAC inhibitors in combination with radiation or chemotherapy (e.g., NCT04315064, NCT04351380), while studies in gliomas or pediatric high-grade gliomas may offer insights transferable to MB [18,28].